Treatment of vaginitis

International Journal of Gynecology and Obstetrics

Volumn 52, Issue 1, 1996, Pages 43-47

  Kukner S ^a   Ergin, T ^a   Cicek N ^a   Ugur M ^a   Yesilyurt H ^a   Gokmen O ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bacterial vaginosis; Candida albicans; Gardnerella vaginalis; Metronidazole; Miconazole; Trichomonas vaginalis; Vaginitis

Indexed keywords

METRONIDAZOLE; MICONAZOLE NITRATE; NEO-PENOTRAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL INFECTION; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DYSURIA; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRURITUS; RECURRENT INFECTION; STATISTICAL ANALYSIS; TRICHOMONIASIS; VAGINA PESSARY; VAGINITIS;

EID: 0343338077     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(95)02531-6     Document Type: Article

References (29)

1. Lugo-Miro VI, Mitre G, Lynette M. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. J Am Med Assoc 1992; 268: 92-95.
2. Morton O. Neotran - a new double-active pessary for the treatment of vaginitis. J Int Med Res 1993; 21: 36-46.
3. Brocklehurst P, Mindel A. Recurrent genital infections. Br J Sex Med 1991; 18: 54-57.
4. Pheifer TA, Forsyth PS, Durfee MA et al. Non-specific vaginitis: role of Hemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978; 298: 1429-1434.
5. Amsel R, Totter PA, Spiegel CA et al. Non-specific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
6. Nelson MS. Clinical diagnosis of bacterial vaginosis. Am J Emerg Med 1987; 5: 488-491.
7. Eileen S. The management of Candida infections. Practitioner 1990; 234: 232-236.
8. Bump RC, Zuspan FP, Buesching WJ, Ayers LW, Stephen TJ. The prevalence, six months' persistence and predictive values of laboratory indicators of bacterial vaginosis in symptomatic women. Am J Obstet Gynecol 1984; 150: 917-924.
9. Mohanty KC. Bacterial vaginosis. Br J Sex Med 1991; 18: 38-39.
10. Blackwell AI, Fox AR, Phillips I, Barlow D. Anaerobic vaginosis (non-specific vaginitis). Clinical, microbiological and therapeutic findings. Lancet 1983; ii: 1379-1383.
11. Malouf M, Fortier M, Morin G, Dube JL. Treatment of Hemophilus vaginalis vaginitis. Obstet Gynecol 1981; 54: 711-714.
12. Singha HSK, Deventra SV. Local therapy for bacterial vaginosis. Br J Sex Med 1989; 16: 235-240.
13. British Co-operative Clinical Group. An investigation, by questionnaire, of recalcitrant vaginal trichomoniasis seen in genitourinary medicine clinics in the United Kingdom. Int J Std Aids 1992; 3: 24-27.
14. 14C-M) after its oral (po) and intravaginal administration to female subjects (abstract 60). In: 18th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia, 1978. Washington DC: American Society for Microbiology, 1978.
15. Fleury FJ. Recurrent Candida vulvovaginitis. Chemotherapy 1982; 28 Suppl 1: 48-50.
16. Peeters F, Snawaert R, Van Cutsen J et al. A controlled trial with miconazole in the prevention of yeast infections occurring after treatment of vaginal Trichomonas. Eur J Obstet Gynecol Reprod Biol 1974; 4: 95-99.
17. Bistoletti P, Fredricsson B, Hagstrom B et al. Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 1986; 21: 144-149.
18. Bro F. Metronidazole pessaries compared with placebo in the treatment of bacterial vaginosis. Scand J Prim Health Care 1990; 8: 219-223.
19. Ison CA, Taylor RFH, Link C et al. Local treatment for bacterial vaginosis. Br Med J 1987; 295: 886-890.
20. Sharma JB, Buckshee K, Gulati N. Oral ketoconazole and miconazole vaginal pessary treatment for vaginal candidiasis. Aust N Z J Obstet Gynaecol 1991; 31: 276.
21. Corson SL, Kafikian RR, Nehring R. Terconazole and miconazole cream for treating vulvovaginal candidiasis. J Reprod Med 1991; 36: 561-567.
22. Kaufman RH, Henzl MR, Brown D et al. Comparison of three-day butaconazole treatment with seven-day miconazole treatment for vulvovaginal disorders. J Reprod Med 1989; 34: 479-483.
23. Dinsmore WW, Granger SE. An open study to assess the acceptability and effectiveness of miconazole 1200 mg single ovule in the treatment of acute vaginal candidiasis. Br J Clin Pract 1989; 43: 238-241.
24. Brown D, Henzl MR, Le Page ME et al. Butaconazole vaginal cream in the treatment of vulvovaginal candidiasis: comparison with miconazole nitrate and placebo. J Reprod Med 1986; 31: 1045-1046.
25. Mohanty KC, Deighton R. Comparison of 2 g single dose of metronidazole, nimorazole, and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. J Antimicrob Chemother 1987; 19: 393-399.
26. Eschenbach DA, Crithlow CW, Watkin H et al. A dose duration study of metronidazole for the treatment of non-specific vaginosis. Scand J Infect Dis 1983; 40 (Suppl): 73-80.
27. Fuyton A, Hanna JH, Morse PL, Paine DD, Engelkirk PG. An evaluation of single dose metronidazole treatment for Gardnerella vaginalis vaginitis. Obstet Gynecol 1984; 64: 271-274.
28. Swedberg J, Steiner JF, Deiss T, Steiner S, Priggers DA. Comparison of single dose versus one week course of metronidazole for symptomatic bacterial vaginosis. J Am Med Assoc 1985; 254: 1046-1049.
29. Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. Morbid Mortal Week Rep 1989; 38: 36-37.